Immune checkpoint inhibitor in recurrent hypermutated glioblastoma with POLE mutation

Sith SathornsumeteeSarun Nunta-AreePornsuk CheunsuchonSiriraj Hospital2022-08-042022-08-042021-01-01Neuro-Oncology Advances. Vol.3, No.1 (2021)263224982-s2.0-85126678412https://repository.li.mahidol.ac.th/handle/20.500.14594/78517Mahidol UniversityMedicineImmune checkpoint inhibitor in recurrent hypermutated glioblastoma with POLE mutationArticleSCOPUS10.1093/noajnl/vdab093